- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 47/26 - Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharidesDerivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
Patent holdings for IPC class A61K 47/26
Total number of patents in this class: 9602
10-year publication summary
|
685
|
805
|
832
|
968
|
1030
|
1193
|
1133
|
1103
|
1103
|
490
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 4223 |
89 |
| Amgen Inc. | 4047 |
74 |
| Azurity Pharmaceuticals, Inc. | 210 |
65 |
| Takeda Pharmaceutical Company Limited | 2704 |
64 |
| Novartis AG | 10904 |
61 |
| Genentech, Inc. | 3961 |
60 |
| Allergan, Inc. | 2362 |
54 |
| Pfizer Inc. | 3367 |
45 |
| Hoffmann-La Roche Inc. | 3379 |
42 |
| Chiesi Farmaceutici S.p.A. | 952 |
42 |
| Chugai Seiyaku Kabushiki Kaisha | 1334 |
42 |
| Merck Sharp & Dohme LLC | 3741 |
41 |
| Astellas Pharma Inc. | 1086 |
39 |
| Alkermes Pharma Ireland Limited | 271 |
38 |
| Daiichi Sankyo Company, Limited | 1852 |
38 |
| F. Hoffmann-La Roche AG | 7926 |
36 |
| Janssen Biotech, Inc. | 1531 |
36 |
| Hanmi Pharm. Co., Ltd. | 569 |
34 |
| Coherus Biosciences, Inc. | 134 |
30 |
| Fertin Pharma A/S | 252 |
29 |
| Other owners | 8643 |